What is the GDF?
This group of four fact sheets explain the origin and purpose of the Global Drug Facility (GDF), how the GDF works, how to apply to the GDF for a grant of TB drugs, and how to buy drugs through the GDF.
This group of four fact sheets explain the origin and purpose of the Global Drug Facility (GDF), how the GDF works, how to apply to the GDF for a grant of TB drugs, and how to buy drugs through the GDF.
This report explains the European DOTS Expansion plan to control TB. The plan highlights country needs and resource gaps, emphasizing collaboration with the governments of endemic countries, national and international agencies, and nongovernmental organizations (NGOs). The aim is to stimulate social...
This guideline sets forth the framework to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. The framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programs.
The Effective TB Interviewing for Contact Investigations Materials include a Faciltator-Led Training Guide, Self-Study Modules, and a Videotape. The materials can be used together or on their own. Each material has to be ordered separately from the CDC website order form. This 67-minute videotape...
This pocket-size drug treatment information card for clinicians provides information on the standard anti-tuberculosis therapy for active disease in adults, including dosages, daily and intermittent regimens, side effects, treatment information, and visual depictions of first-line medications.
This guide provides information about TB treatment for TB supporters who ensure that patients take their TB drugs regularly and on schedule for the full duration of the treatment.
This report discusses compounds with potential for the treatment of TB and categorizes them into the discovery, preclinical, or clinical phases of development.
This resource presents a method of assessing and updating laboratory procedures to assist in detecting TB early by reducing lab turnaround time for reporting positive smear, culture, identification, and susceptibility results.
This report presents a regional framework for addressing TB/HIV co-infection in the Western Pacific that is adapted to the epidemiological profile and health service system of the region and identifies areas in which both programs can complement each other to address TB/HIV.
This wall chart illustrates the key steps in administration and reading of the TB skin test, and describes the cutpoints for interpretation of the skin test. Dimensions: 24 1/4 x 27 1/2 in.